Bringing Animal Health Serology In-House

The Most Comprehensive Bartonella IFA Panel Available for animal health

 

We are excited to announce the Bartonella IFA Serology Panel for veterinary diagnostics will be run in our laboratory starting August 1st, 2022. We will continue offering three IFA serology tests for antibodies specific to the following antigens: B. henselae, B. koehlerae, and B. vinsonii berkhoffii.

Published data shows a specificity of 97% for B. henselae, B. vinsonii berkhoffii, and B. koehlerae in nearly 16,000 dogs that were suspected of having a vector-borne infection.

 

Galaxy Diagnostics is committed to providing quality diagnostic testing.

 

Bringing the Bartonella IFA serology animal health panel in house:
• Allows us to oversee quality of the test
• Create a more efficient lab workflow
• Support our continued growth

B. henselae infection has been documented worldwide in people who live and work with animals, especially veterinary workers, and can lead to systemic disease affecting the heart, eyes, joints, and central nervous system. Transmission is thought to occur primarily through contact with cats and fleas.

B. vinsonii berkhoffii infection has been documented worldwide in people who live and work with animals, especially veterinary workers, and can lead to systemic diseases. Transmission is thought to occur primarily in the context of contact with dogs and fleas.

B. koehlerae infection is associated with cats and their fleas, like B. henselae, and has been implicated in illnesses impacting the central nervous system in people. Commercial testing for this species is not available anywhere else in the world at this time.

Confidently confirming infection is incredibly important for you and your patients. Our mission is to provide clinicians like you with more sensitive direct detection methods powered by revolutionary sample enrichment technologies for elusive flea and tick borne pathogens. As a One Health company backed by published science, we offer better testing options to researchers, clinicians and veterinarians in emerging infectious disease.